Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
East African Medical Journal|March 5, 1999
Colorectal neoplasms: a retrospective studyS O Elesha, T K OwonikokoOncogene|April 12, 2011
Oncogenic role of EAPII in lung cancer development and its activation of the MAPK-ERK pathwayC Li, S Fan, T K Owonikoko, et al.Oncogene|April 14, 2015
Inhibition of B-Raf/MEK/ERK signaling suppresses DR5 expression and impairs response of cancer cells to DR5-mediated apoptosis and T cell-induced killingY-T Oh, J Deng, P Yue, et al.Current Oncology (Toronto, Ont.)|December 31, 2015
Analysis of liver-directed therapies in U.S. cancer patientsO B Alese, S Kim, Z Chen, et al.Cell Death and Differentiation|April 29, 2014
Role of Ku70 in deubiquitination of Mcl-1 and suppression of apoptosisB Wang, M Xie, R Li, et al.British Journal of Cancer|January 17, 2013
A phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor malignanciesR D Harvey, T K Owonikoko, C M Lewis, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2019
Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trialJ M Weiss, T Csoszi, M Maglakelidze, et al.Pageof 1